Search by Drug Name or NDC
NDC 72516-0024-25 Papaverine Hydrochloride 30 mg/mL Details
Papaverine Hydrochloride 30 mg/mL
Papaverine Hydrochloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Oryza Pharmaceuticals Inc.. The primary component is PAPAVERINE HYDROCHLORIDE.
Product Information
| NDC | 72516-0024 |
|---|---|
| Product ID | 72516-024_e6894d2b-727f-4cef-a0ba-ab408584fee9 |
| Associated GPIs | 40100060102005 |
| GCN Sequence Number | 000527 |
| GCN Sequence Number Description | papaverine HCl VIAL 30 MG/ML INJECTION |
| HIC3 | A7C |
| HIC3 Description | VASODILATORS,PERIPHERAL |
| GCN | 02100 |
| HICL Sequence Number | 000170 |
| HICL Sequence Number Description | PAPAVERINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Papaverine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Papaverine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/mL |
| Substance Name | PAPAVERINE HYDROCHLORIDE |
| Labeler Name | Oryza Pharmaceuticals Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72516-0024-25 (72516002425)
| NDC Package Code | 72516-024-25 |
|---|---|
| Billing NDC | 72516002425 |
| Package | 25 VIAL in 1 CARTON (72516-024-25) / 2 mL in 1 VIAL |
| Marketing Start Date | 2021-02-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |